DE
Stocks › United States › Nasdaq 100 › DexCom

DexCom Stock Forecast & Price Target

Ticker DXCM ISIN US2521311074
79.88USD
−$0.19 (−0.24%)today
Real-time As of Nov 11, 2026, 9:11 AM ET
Quantum Forecast Range band

DexCom Price Target 2026

The Quantum Forecast sees a price target of $83.19 (+4.1%) for DexCom in about one month (by Dec 10, 2026).

Quantum Forecast price targets by time frame, calculated from the current price of $79.88. Click to see the forecast in the chart.

Time framePrice targetChangeRange band
1 monthby Dec 10, 2026 · Chart 6M$83.19 ▲ +4.1% $72.17 – $94.21
2 monthsby Jan 8, 2027 · Chart 1Y$75.07 ▼ −6.0% $60.63 – $89.51
6 monthsby May 12, 2027 · Chart 3Y$92.34 ▲ +15.6% $58.85 – $125.83
10 monthsby Sep 15, 2027 · Chart 5Y$90.10 ▲ +12.8% $45.44 – $134.76

DexCom Forecast for Today and Tomorrow

In the short term, the Quantum Forecast sees DexCom at $79.70 (−0.22%) today around 11 AM ET and at $79.92 (+0.06%) today around 3:15 PM ET. It is based on prices from the current trading day and the past week. Short-term forecast in the chart

DexCom Stock 2026: Price Performance

DexCom stock has gained 20.3% since the start of 2026 and currently trades at $79.88 (as of Nov 11, 2026). Over the same period the Nasdaq 100 is up 11.9%, putting the stock 8.4 percentage points ahead of the index. Over the past 52 weeks the price ranged between $56.66 and $92.65; it is currently 13.8% below its high of Aug 21, 2026.

DexCom Forecast 2027

Over a horizon of roughly 10 months (until about Sep 2027), the Quantum Forecast sees a price target of $90.10 for DexCom – +12.8% from today. The range band runs from $45.44 – $134.76: the further ahead the forecast looks, the greater the uncertainty. See the long-term forecast in the chart

Community Forecast for DexCom

There are no user forecasts for DexCom yet – be the first to make one.

Make your own forecast

About DexCom

DexCom, Inc. develops continuous glucose monitoring (CGM) systems for people with diabetes. Founded in 1999 and headquartered in San Diego, California, the company makes small wearable sensors that measure glucose levels under the skin every few minutes and send readings to a smartphone, receiver or insulin pump. Its main product line is the Dexcom G7, alongside the G6 and Stelo, an over-the-counter biosensor for people with type 2 diabetes who do not use insulin.

DexCom sells through pharmacies, distributors and directly to patients, with reimbursement from health insurers and public programs such as Medicare. The United States is the largest market, followed by Europe and other international regions. Its sensors integrate with automated insulin delivery systems from partners like Tandem and Insulet. Growth depends on expanding insurance coverage to more people with type 2 diabetes, competition from Abbott's FreeStyle Libre, product quality issues, and pricing pressure. DexCom trades on the Nasdaq under the ticker DXCM and belongs to the Nasdaq-100 and S&P 500.

The current price of DexCom stock is $79.88 (−0.24% vs. the previous close). In today's trading the high was $80.16 and the low $79.38.

Indices Nasdaq 100, S&P 500Region United States Currency USD Price history since 2006

How the Quantum Forecast works

  1. Research from quantum physics. The models are the result of several years of research at the Max Planck Institute of Quantum Optics and LMU Munich and were transferred to the stock market.

  2. Spectra and correlations. Frequency spectra are calculated from current prices, and the relationships between price swings and volatility are analyzed. This produces the forecast and the risk assessment.

  3. Detecting herd behavior. Models of phase transitions from statistical physics describe when investors collectively fall into panic or euphoria – an early sign of possible crash situations.

  4. Swarm intelligence. User forecasts are checked once their time frame has expired and feed into the model, weighted by their hit rate.

The range band shows the typical fluctuation around the forecast. More on quantum physics & swarm intelligence

Frequently Asked Questions about DexCom Stock

What is the DexCom stock forecast?

The Quantum Forecast expects DexCom to reach $83.19 in about one month (by Dec 10, 2026), a change of +4.1% from the current price of $79.88. Over roughly 10 months (by Sep 2027) the price target is $90.10 (+12.8%).

What is the DexCom stock price target?

Quantum Forecast price targets by time frame: 1 month $83.19 (+4.1%), 2 months $75.07 (−6.0%), 6 months $92.34 (+15.6%), 10 months $90.10 (+12.8%). The range band shows the typical fluctuation around these targets.

Will DexCom stock go up or down?

In the short term the Quantum Forecast points up (+4.1% over one month). No forecast is certain – it is based on historical prices and statistical analysis.

How is the Quantum Forecast computed?

Trends, frequency spectra and correlations are calculated from the price history using methods from quantum physics; user opinions are added as well (swarm intelligence). The range band reflects the volatility of the security and widens with the time horizon.

Can I make my own forecast for DexCom?

Yes – in the Forecast League you pick long or short and a price target for 1 day up to 6 months. Forecasts are scored automatically when they expire; correct calls earn points and a spot on the leaderboard.

WelcomeSave your watchlist and forecasts across all your devices

My stuff

WatchlistSaved stocks Price alertssoon

Display

Sprache · Language

Deutsch